Followers | 7 |
Posts | 651 |
Boards Moderated | 0 |
Alias Born | 04/24/2006 |
![](https://investorshub.advfn.com/uicon/70995.png?cb=1625155180)
Friday, July 08, 2022 11:04:01 AM
2. Current status as a non-shell company: I am of the opinion that ONPH is not currently a
shell company based upon the following:
a. The 2022 Annual Reports reveal that ONPH is engaged in the business of licensing,
developing, manufacturing and commercializing therapeutics.
b. ONPH, per an agreement with Sybleu Therapeutics, has been granted an exclusive world?wide license to develop its cancer therapy. ONPH has also been granted a license by
NanoSmart Pharmaceuticals Inc. for its "novel" drug delivery platform targeting many
types of cancer and other diseases. ONPH has also been granted a license by KCL
Therapeutics Inc., a wholly owned subsidiary of Regen Biopharma to develop a treatment
for human colon cancer; and a license with Ribera Solutions to develop its clinical trial
patient retention app.
c. ONPH is currently engaged in an active trade or business.
d. For the fiscal year ended March 31, 2022 Annual report, cash constitutes less than 2.5%
of total assets.
e. For the fiscal year ended March 31, 2022, ONPH reported operating expenses (exclusive
of depreciation expense) of $61,201.00. ONPH also made investments in licensing
agreements with NanoSmart Pharmaceuticals for $351,350, KCL Therapeutics for
$1,400,000; Regen Biopharma $55,000; and Ribera Solutions $75,000. These operations
and investments demonstrate greater than nominal operations for a company in this stage
of development. The financial statements of ONPH are consistent with an operating
business.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM